Search research articles
Contact Us
Filters
Showing results (171-180 of 314) with videos related to
Page
of 32
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 25, 2010
Extent and patterns of MGMT promoter methylation in glioblastoma- and respective glioblastoma-derived spheres
Davide Sciuscio, Annie-Claire Diserens, Kristof van Dommelen, et al.
Neuro-Oncology
|
September 20, 2013
New validated prognostic models and prognostic calculators in patients with low-grade gliomas diagnosed by central pathology review: a pooled analysis of EORTC/RTOG/NCCTG phase III clinical trials
Thierry Gorlia, Wenting Wu, Meihua Wang, et al.
International Journal of Cancer
|
June 13, 2009
Elevated levels of MIC-1/GDF15 in the cerebrospinal fluid of patients are associated with glioblastoma and worse outcome
Sophie Shnaper, Isabelle Desbaillets, David A Brown, et al.
JCI Insight
|
February 3, 2026
Consideration of spatial companion biomarkers for targeted therapeutics in cancer: depatuxizumab mafodotin in glioblastoma
Rimas V Lukas, Ruochen Du, Harrshavasan Congivaram, et al.
Cancer
|
January 24, 2008
Cost-effectiveness of temozolomide for the treatment of newly diagnosed glioblastoma multiforme: a report from the EORTC 26981/22981 NCI-C CE3 Intergroup Study
Leida M Lamers, Roger Stupp, Martin J van den Bent, et al.
Neuro-Oncology Advances
|
June 12, 2026
Development of skull-implanted ultrasound for blood-brain barrier opening and drug delivery in neuro-oncology
Karl J Habashy, Victor A Arrieta, Benedikt Haupt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 15, 2012
Phase II study of imatinib in advanced chordoma
Silvia Stacchiotti, Alessandra Longhi, Virginia Ferraresi, et al.
Neuro-Oncology
|
August 5, 2008
A novel tool to analyze MRI recurrence patterns in glioblastoma
Wolfgang Wick, Roger Stupp, Anna-Carina Beule, et al.
Acta Neuropathologica
|
September 28, 2018
cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV"
Daniel J Brat, Kenneth Aldape, Howard Colman, et al.
The Lancet. Oncology
|
December 18, 2007
Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3
Thierry Gorlia, Martin J van den Bent, Monika E Hegi, et al.
Page
of 32
Search research articles
Search
Showing results (171-180 of 314) with videos related to
Sort By:
Page
of 32
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 25, 2010
Extent and patterns of MGMT promoter methylation in glioblastoma- and respective glioblastoma-derived spheres
Davide Sciuscio, Annie-Claire Diserens, Kristof van Dommelen, et al.
Neuro-Oncology
|
September 20, 2013
New validated prognostic models and prognostic calculators in patients with low-grade gliomas diagnosed by central pathology review: a pooled analysis of EORTC/RTOG/NCCTG phase III clinical trials
Thierry Gorlia, Wenting Wu, Meihua Wang, et al.
International Journal of Cancer
|
June 13, 2009
Elevated levels of MIC-1/GDF15 in the cerebrospinal fluid of patients are associated with glioblastoma and worse outcome
Sophie Shnaper, Isabelle Desbaillets, David A Brown, et al.
JCI Insight
|
February 3, 2026
Consideration of spatial companion biomarkers for targeted therapeutics in cancer: depatuxizumab mafodotin in glioblastoma
Rimas V Lukas, Ruochen Du, Harrshavasan Congivaram, et al.
Cancer
|
January 24, 2008
Cost-effectiveness of temozolomide for the treatment of newly diagnosed glioblastoma multiforme: a report from the EORTC 26981/22981 NCI-C CE3 Intergroup Study
Leida M Lamers, Roger Stupp, Martin J van den Bent, et al.
Neuro-Oncology Advances
|
June 12, 2026
Development of skull-implanted ultrasound for blood-brain barrier opening and drug delivery in neuro-oncology
Karl J Habashy, Victor A Arrieta, Benedikt Haupt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 15, 2012
Phase II study of imatinib in advanced chordoma
Silvia Stacchiotti, Alessandra Longhi, Virginia Ferraresi, et al.
Neuro-Oncology
|
August 5, 2008
A novel tool to analyze MRI recurrence patterns in glioblastoma
Wolfgang Wick, Roger Stupp, Anna-Carina Beule, et al.
Acta Neuropathologica
|
September 28, 2018
cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV"
Daniel J Brat, Kenneth Aldape, Howard Colman, et al.
The Lancet. Oncology
|
December 18, 2007
Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3
Thierry Gorlia, Martin J van den Bent, Monika E Hegi, et al.
Page
of 32